tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market
SUPN
Supernus Pharmaceuticals
RESEARCH TOOLSreports
Want to see SUPN full AI Analyst Report?

Supernus Pharmaceuticals (SUPN) Balance Sheet

532 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q1 2026 were $1.50B, an increase of 3.31% from the previous quarter. SUPN total liabilities were $423.92M for the fiscal quarter, a 8.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.45B$ 1.37B$ 1.28B$ 1.70B$ 1.69B
Total Liabilities
$ 390.93M$ 332.34M$ 356.16M$ 816.30M$ 873.30M
Total Equity Gross Minority
$ 1.06B$ 1.04B$ 921.52M$ 886.20M$ 815.85M
Other Metrics
Currency in USD

Supernus Pharmaceuticals Debt to Assets